Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion type Assertion NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_head.
- NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion description "[We now report that MHC II-matched allogeneic vaccines, prepared from primary uveal melanomas that arise in the immune-privileged eye, prime and boost IFNgamma-secreting CD4(+) T cells from the peripheral blood of either healthy donors or uveal melanoma patients that cross-react with primary uveal melanomas from other patients and metastatic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_provenance.
- NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion evidence source_evidence_literature NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_provenance.
- NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion SIO_000772 17483366 NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_provenance.
- NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion wasDerivedFrom befree-2016 NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_provenance.
- NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_assertion wasGeneratedBy ECO_0000203 NP608520.RAFfkCXpEeBZIz7y_EuWNL4BQl4icEpeoroFp19oJf_rk130_provenance.